Change of immunologic phenotype in an atypical case of prolymphocytic leukemia--role of interferon alpha
Cedrych, I.; Krzemień, S.; Hołowiecki, J.
Polski Tygodnik Lekarski 49(12-13): 294-295
1994
ISSN/ISBN: 0032-3756 PMID: 7808957 Document Number: 426483
Document emailed within 1 workday
Related Documents
Ando, S.; Ando, S.; Otani, N.; Kanbe, T. 1993: A case of B-chronic lymphocytic leukemia/prolymphocytic leukemia (CLL/PL) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(1): 153-156Forman, S.J.; Nathwani, B.N.; Woda, B.A.; Paladugu, R.R.; Farbstein, M.J. 1985: Clonal evolution of T-cell prolymphocytic leukemia to a T-large-cell lymphoma. a morphologic and immunologic study Archives of Pathology and Laboratory Medicine 109(12): 1081-1084
Federowicz, I.; Sułek, K.; Mielcarek, W. 1988: A case of prolymphocytic leukemia Polski Tygodnik Lekarski 43(33): 1063-1065
Russo, D.; Fanin, R.; Zuffa, E.; Damiani, D.; Gallizia, C.; Michieli, M.; Testoni, N.; Benfenati, D.; Visani, G.; Zaccaria, A. 1990: Sequential treatment of Ph-positive chronic myeloid leukemia with interferon gamma and interferon alpha Haematologica 75(4): 334-339
Ziegler-Heitbrock, H.W.; Munker, R.; Dörken, B.; Gaedicke, G.; Thiel, E. 1986: Induction of features characteristic of hairy cell leukemia in chronic lymphocytic leukemia and prolymphocytic leukemia cells Cancer Research 46(4 Pt 2): 2172-2178
Aboín Massieu, F.J.; Sanz Marca, A.; Villegas Martínez, A. 1982: Prolymphocytic transformation in chronic lymphatic leukemia. Comments apropos of a clinical case Revista Clinica Espanola 165(1): 69-71
Phyliky, R.L.; Li, C.Y.; Yam, L.T. 1983: T-cell chronic lymphocytic leukemia with morphologic and immunologic characteristics of cytotoxic/suppressor phenotype Mayo Clinic Proceedings 58(11): 709-720
Schwarzinger, I.; Bettelheim, P.; Chott, A.; Herold, C.; Hinterberger, W.; Köller, U.; Kos, M.; Neumann, E.; Radaszkiewicz, T.; Lechner, K. 1988: Recombinant alpha-interferon (alpha-IFN) for progressive hairy-cell leukemia (HCL): a study in previously untreated nonsplenectomized patients Wiener Klinische Wochenschrift 100(2): 47-51
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Stanojević-Bakić, N.; Vucković-Dekić, L.; Inić, M.; Tomin, R. 1994: Immunologic reactivity in patients with breast carcinoma treated with interferon alpha Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 44: 71-82
Stathopoulos, G.P.; Baxevanis, C.N.; Papadopoulos, N.G.; Zarkadis, I.K.; Papacostas, P.; Michailakis, E.; Tsiatas, M.L.; Papamichail, M. 1996: Local immunotherapy with interferon-alpha in metastatic pleural and peritoneal effusions: correlation with immunologic parameters Anticancer Research 16(6b): 3855-3860
Chorváth, B.; Sedlák, J.; Duraj, J.; Klobusická, M.; Plesková, I.; Augustinová, M.; Suliková, M. 1990: Biochemical and immunological phenotype alterations in human monoblastoid cell line U-937 induced by physiological (interferon-alpha, retinoic acid) and nonphysiological (phorbol ester) inducers Neoplasma 37(3): 317-331
Faber, E.; Jarosová, M.; Divoký, V.; Luhový, M.; Komenda, S.; Sulovská, I.; Hubácek, J.; Slezák, P.; Papajik, T.; Raida, L.; Heczko, M.; Indrák, K. 1997: Interferon-alpha in the treatment of patients with chronic myeloid leukemia Vnitrni Lekarstvi 43(1): 13-17
Flandrin, G. 1993: Interferon-alpha in the treatment of hairy cell leukemia. new perspectives Presse Medicale 22(1): 9-12
Gotić, M.; Rolović, Z.; Vuković, S.; Elezović, I.; Tomić, D. 1990: Use of alpha-interferon in the treatment of patients with hairy cell leukemia Srpski Arhiv Za Celokupno Lekarstvo 118(7-8): 277-284
Klener, P.; Háber, J.; Hausner, P. 1989: Alpha-2b interferon in the treatment of advanced chronic lymphocytic leukemia Neoplasma 36(2): 215-220
Ezaki, K. 2000: Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 279-284
Uehara, E.; Uesugi, T.; Tasaka, T.; Matsuhashi, Y.; Tamura, T.; Kuwajima, M.; Nagai, M. 2002: Reversible cardiomyopathy secondary to interferon-alpha in chronic myelogenous leukemia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(2): 317-321
Ladoyanni, E.; Nambi, R. 2005: Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia Journal of Drugs in Dermatology: Jdd 4(2): 221-222
Gavrilova, I.E.; Kuznetsov, I.P.; Denisov, L.A.; Maiakova, S.A.; Orlova, T.G.; Kadagidze, Z.G.; Makhonova, L.A. 1991: Use of alpha interferon preparations in acute lymphoblastic leukemia in children during remission Pediatriia 11: 75-78